Towards High Definition, Individualised Medicine - a public lecture by Professor Eric Topol Event as iCalendar

07 February 2018


Venue: AMRF Lecture Theatre, 505-011, Building 505, Ground floor

Location: 85 Park Road, Grafton

Contact email:

Image reads Public Lecture: Towards High-Definition, Individualized Medicine. Professor Eric Topol, Dirctor, Scripps Transnational Science Institute, 5p, Wednesday 7 February
Professor Eric Topol



Until now, we have largely practiced shallow medicine due to lack of understanding of the medical essence of each individual. But we now have the tools to transcend that era, with sensors, sequencing, and integration of big data for each person (including biology, physiology, social and behavioural, immunology, environment, microbiome).  

This high definition “Google map” or digitised human being sets up individualized medicine, with the added feature that much of the data in the future will be generated by the person, rather than the way it has been done traditionally. Not only does this democratise medical data, but it promotes far more personal engagement. 

Furthermore, artificial intelligence to process all the information, and particularly the subtype of deep learning, has remarkable power for transforming medicine’s future.

In his public lecture Professor Topol will discuss the implications of these 3 D’s (digitisation, democratisation and deep learning) and what can be done to achieve implementation in the clinic.



Professor Topol is the Director and Professor of Genomics at The Scripps Translational Science Institute. He is one the world’s foremost experts in digital medicine and currently holds the largest single NIH grant, USD204 million to lead the precision medicine Initiative in the USA, involving 1 million Americans supported by former president Barack Obama and announced in his 2015 State of the Nation address.   

An internationally acclaimed cardiologist and formally Chief of Cardiology at the Cleveland Clinic, Professor Topol is editor-in-chief of Medscape and In 2012, he published a book called The Creative Destruction of Medicine which examined the impact of both the genomic and wireless revolutions on the health care system. His most recent book The Patient Will See You Now, published in 2015, explores how smartphones, big data, and technology are combining to democratise health care. In 2016, he co-founded the company YouBase which develops an individual-centric health data platform.

Professor Topol’s research has pioneered many medications that are now routinely used in medical practice including t-PA, Plavix, Angiomax, and ReoPro.  He continues to be interested in new medications and the application of genomics in personalised medicine.  He gained worldwide prominence in 2004 as the first physician-scientist to raise doubts about the safety of the anti-inflammatory drug Vioxx, which was ultimately withdrawn after evidence that it increased patient-risk to heart attack and stroke.


To RSVP, please email with the subject "Professor Eric Topol" by 31 January.